New

Biopharmaceutical CMO and CRO Market

2021

Biopharmaceutical CMO and CRO Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Mammalian, Non-Mammalian); Service Type (Contract Manufacturing, Contract Research); Product (Biologics, Biosimilars) and Geography

| Report Code: TIPRE00007162 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming

Market Insights

Biopharmaceutical CMO and CRO Market 2028 By Source, Service Type, Product and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

A contract research organization (CRO) is an enterprise that offers research and development services to the pharmaceutical and biotechnology industries. These companies collaborate with other companies to arrange and conduct clinical trials in order to test the novel molecule before it is approved. Contract manufacturing organizations (CMOs) provide manufacturing services in a range of volumes, from small amounts for preclinical research and development to larger volumes required for clinical trials and commercialization.

MARKET SCOPE

The Global Biopharmaceutical CMO And CRO Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the biopharmaceutical CMO and CRO market with detailed market segmentation by source, service type and product. The report provides key statistics on the market status of the leading biopharmaceutical CMO and CRO market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on source the market is segmented as, mammalian and non-mammalian.
  •   Based on service type the market is segmented as, contract manufacturing and contract research.
  •   Based on product the market is bifurcated as, biologics and biosimilars.

MARKET DYNAMICS
Drivers:

  •   Increasing R&D expenditures by biopharmaceutical companies and rising outsourcing activities.
  •   Increasing number of clinical trials because of rising pool of novel drug candidates.
  •   Growing demand for biosimilar and generic medicines is also expected to create significant growth opportunities for the market.

Restraints:

  •   However, presence of stringent regulatory framework along with complexities asociated with service are likely to restrain market growth during the forecast period.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biopharmaceutical CMO and CRO market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the biopharmaceutical CMO and CRO market in these regions.

IMPACT OF COVID-19 ON BIOPHARMACEUTICAL CMO AND CRO MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the biopharmaceutical CMO and CRO market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from biopharmaceutical CMO and CRO market are anticipated to lucrative growth opportunities in the future with the rising demand for biopharmaceutical CMO and CRO in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the biopharmaceutical CMO and CRO market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   AGC Biologics
  •   Boehringer Ingelheim International GmbH
  •   FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  •   TOYOBO CO., LTD
  •   JRS PHARMA
  •   Lonza
  •   PRA Health Sciences, Inc.
  •   ProBioGen AG
  •   Rentschler Biopharma SE
  •   Samsung BioLogics
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biopharmaceutical CMO And CRO Market - By Source
1.3.2 Biopharmaceutical CMO And CRO Market - By Service Type
1.3.3 Biopharmaceutical CMO And CRO Market - By Product
1.3.4 Biopharmaceutical CMO And CRO Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BIOPHARMACEUTICAL CMO AND CRO MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. BIOPHARMACEUTICAL CMO AND CRO MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BIOPHARMACEUTICAL CMO AND CRO MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOPHARMACEUTICAL CMO AND CRO - GLOBAL MARKET OVERVIEW
6.2. BIOPHARMACEUTICAL CMO AND CRO - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. BIOPHARMACEUTICAL CMO AND CRO MARKET - REVENUE AND FORECASTS TO 2028 - SOURCE
7.1. OVERVIEW
7.2. SOURCE MARKET FORECASTS AND ANALYSIS
7.3. MAMMALIAN
7.3.1. Overview
7.3.2. Mammalian Market Forecast and Analysis
7.4. NON-MAMMALIAN
7.4.1. Overview
7.4.2. Non-Mammalian Market Forecast and Analysis
8. BIOPHARMACEUTICAL CMO AND CRO MARKET - REVENUE AND FORECASTS TO 2028 - SERVICE TYPE
8.1. OVERVIEW
8.2. SERVICE TYPE MARKET FORECASTS AND ANALYSIS
8.3. CONTRACT MANUFACTURING
8.3.1. Overview
8.3.2. Contract Manufacturing Market Forecast and Analysis
8.3.3. Analytical and QC studies Market
8.3.3.1. Overview
8.3.3.2. Analytical and QC studies Market Forecast and Analysis
8.3.4. Fill and Finish Operations Market
8.3.4.1. Overview
8.3.4.2. Fill and Finish Operations Market Forecast and Analysis
8.3.5. Packaging Market
8.3.5.1. Overview
8.3.5.2. Packaging Market Forecast and Analysis
8.3.6. Process Development Market
8.3.6.1. Overview
8.3.6.2. Process Development Market Forecast and Analysis
8.4. CONTRACT RESEARCH
8.4.1. Overview
8.4.2. Contract Research Market Forecast and Analysis
8.4.3. Cardiology Market
8.4.3.1. Overview
8.4.3.2. Cardiology Market Forecast and Analysis
8.4.4. Inflammation and Immunology Market
8.4.4.1. Overview
8.4.4.2. Inflammation and Immunology Market Forecast and Analysis
8.4.5. Neuroscience Market
8.4.5.1. Overview
8.4.5.2. Neuroscience Market Forecast and Analysis
8.4.6. Oncology Market
8.4.6.1. Overview
8.4.6.2. Oncology Market Forecast and Analysis
8.4.7. Other Types Market
8.4.7.1. Overview
8.4.7.2. Other Types Market Forecast and Analysis
9. BIOPHARMACEUTICAL CMO AND CRO MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
9.1. OVERVIEW
9.2. PRODUCT MARKET FORECASTS AND ANALYSIS
9.3. BIOLOGICS
9.3.1. Overview
9.3.2. Biologics Market Forecast and Analysis
9.3.3. Antisense RNAi Market
9.3.3.1. Overview
9.3.3.2. Antisense RNAi Market Forecast and Analysis
9.3.4. and Molecular Therapy Market
9.3.4.1. Overview
9.3.4.2. and Molecular Therapy Market Forecast and Analysis
9.3.5. Monoclonal Antibodies (MAbs) Market
9.3.5.1. Overview
9.3.5.2. Monoclonal Antibodies (MAbs) Market Forecast and Analysis
9.3.6. Recombinant Proteins Market
9.3.6.1. Overview
9.3.6.2. Recombinant Proteins Market Forecast and Analysis
9.3.7. Vaccines Market
9.3.7.1. Overview
9.3.7.2. Vaccines Market Forecast and Analysis
9.3.8. Other Biologics Market
9.3.8.1. Overview
9.3.8.2. Other Biologics Market Forecast and Analysis
9.4. BIOSIMILARS
9.4.1. Overview
9.4.2. Biosimilars Market Forecast and Analysis

10. BIOPHARMACEUTICAL CMO AND CRO MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Biopharmaceutical CMO And CRO Market Overview
10.1.2 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.1.3 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.1.4 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.1.5 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.1.6 North America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.1.6.1 United States Biopharmaceutical CMO And CRO Market
10.1.6.1.1 United States Biopharmaceutical CMO And CRO Market by Source
10.1.6.1.2 United States Biopharmaceutical CMO And CRO Market by Service Type
10.1.6.1.3 United States Biopharmaceutical CMO And CRO Market by Product
10.1.6.2 Canada Biopharmaceutical CMO And CRO Market
10.1.6.2.1 Canada Biopharmaceutical CMO And CRO Market by Source
10.1.6.2.2 Canada Biopharmaceutical CMO And CRO Market by Service Type
10.1.6.2.3 Canada Biopharmaceutical CMO And CRO Market by Product
10.1.6.3 Mexico Biopharmaceutical CMO And CRO Market
10.1.6.3.1 Mexico Biopharmaceutical CMO And CRO Market by Source
10.1.6.3.2 Mexico Biopharmaceutical CMO And CRO Market by Service Type
10.1.6.3.3 Mexico Biopharmaceutical CMO And CRO Market by Product
10.2. EUROPE
10.2.1 Europe Biopharmaceutical CMO And CRO Market Overview
10.2.2 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.2.3 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.2.4 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.2.5 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.2.6 Europe Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Biopharmaceutical CMO And CRO Market
10.2.6.1.1 Germany Biopharmaceutical CMO And CRO Market by Source
10.2.6.1.2 Germany Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.1.3 Germany Biopharmaceutical CMO And CRO Market by Product
10.2.6.2 France Biopharmaceutical CMO And CRO Market
10.2.6.2.1 France Biopharmaceutical CMO And CRO Market by Source
10.2.6.2.2 France Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.2.3 France Biopharmaceutical CMO And CRO Market by Product
10.2.6.3 Italy Biopharmaceutical CMO And CRO Market
10.2.6.3.1 Italy Biopharmaceutical CMO And CRO Market by Source
10.2.6.3.2 Italy Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.3.3 Italy Biopharmaceutical CMO And CRO Market by Product
10.2.6.4 Spain Biopharmaceutical CMO And CRO Market
10.2.6.4.1 Spain Biopharmaceutical CMO And CRO Market by Source
10.2.6.4.2 Spain Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.4.3 Spain Biopharmaceutical CMO And CRO Market by Product
10.2.6.5 United Kingdom Biopharmaceutical CMO And CRO Market
10.2.6.5.1 United Kingdom Biopharmaceutical CMO And CRO Market by Source
10.2.6.5.2 United Kingdom Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.5.3 United Kingdom Biopharmaceutical CMO And CRO Market by Product
10.2.6.6 Rest of Europe Biopharmaceutical CMO And CRO Market
10.2.6.6.1 Rest of Europe Biopharmaceutical CMO And CRO Market by Source
10.2.6.6.2 Rest of Europe Biopharmaceutical CMO And CRO Market by Service Type
10.2.6.6.3 Rest of Europe Biopharmaceutical CMO And CRO Market by Product
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Biopharmaceutical CMO And CRO Market Overview
10.3.2 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.3.3 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.3.4 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.3.5 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.3.6 Asia-Pacific Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Biopharmaceutical CMO And CRO Market
10.3.6.1.1 Australia Biopharmaceutical CMO And CRO Market by Source
10.3.6.1.2 Australia Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.1.3 Australia Biopharmaceutical CMO And CRO Market by Product
10.3.6.2 China Biopharmaceutical CMO And CRO Market
10.3.6.2.1 China Biopharmaceutical CMO And CRO Market by Source
10.3.6.2.2 China Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.2.3 China Biopharmaceutical CMO And CRO Market by Product
10.3.6.3 India Biopharmaceutical CMO And CRO Market
10.3.6.3.1 India Biopharmaceutical CMO And CRO Market by Source
10.3.6.3.2 India Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.3.3 India Biopharmaceutical CMO And CRO Market by Product
10.3.6.4 Japan Biopharmaceutical CMO And CRO Market
10.3.6.4.1 Japan Biopharmaceutical CMO And CRO Market by Source
10.3.6.4.2 Japan Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.4.3 Japan Biopharmaceutical CMO And CRO Market by Product
10.3.6.5 South Korea Biopharmaceutical CMO And CRO Market
10.3.6.5.1 South Korea Biopharmaceutical CMO And CRO Market by Source
10.3.6.5.2 South Korea Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.5.3 South Korea Biopharmaceutical CMO And CRO Market by Product
10.3.6.6 Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market
10.3.6.6.1 Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market by Source
10.3.6.6.2 Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market by Service Type
10.3.6.6.3 Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market by Product
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Biopharmaceutical CMO And CRO Market Overview
10.4.2 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.4.3 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.4.4 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.4.5 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.4.6 Middle East and Africa Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Biopharmaceutical CMO And CRO Market
10.4.6.1.1 South Africa Biopharmaceutical CMO And CRO Market by Source
10.4.6.1.2 South Africa Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.1.3 South Africa Biopharmaceutical CMO And CRO Market by Product
10.4.6.2 Saudi Arabia Biopharmaceutical CMO And CRO Market
10.4.6.2.1 Saudi Arabia Biopharmaceutical CMO And CRO Market by Source
10.4.6.2.2 Saudi Arabia Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.2.3 Saudi Arabia Biopharmaceutical CMO And CRO Market by Product
10.4.6.3 U.A.E Biopharmaceutical CMO And CRO Market
10.4.6.3.1 U.A.E Biopharmaceutical CMO And CRO Market by Source
10.4.6.3.2 U.A.E Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.3.3 U.A.E Biopharmaceutical CMO And CRO Market by Product
10.4.6.4 Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market
10.4.6.4.1 Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market by Source
10.4.6.4.2 Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market by Service Type
10.4.6.4.3 Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market by Product
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Biopharmaceutical CMO And CRO Market Overview
10.5.2 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis
10.5.3 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Source
10.5.4 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Service Type
10.5.5 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Product
10.5.6 South and Central America Biopharmaceutical CMO And CRO Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Biopharmaceutical CMO And CRO Market
10.5.6.1.1 Brazil Biopharmaceutical CMO And CRO Market by Source
10.5.6.1.2 Brazil Biopharmaceutical CMO And CRO Market by Service Type
10.5.6.1.3 Brazil Biopharmaceutical CMO And CRO Market by Product
10.5.6.2 Argentina Biopharmaceutical CMO And CRO Market
10.5.6.2.1 Argentina Biopharmaceutical CMO And CRO Market by Source
10.5.6.2.2 Argentina Biopharmaceutical CMO And CRO Market by Service Type
10.5.6.2.3 Argentina Biopharmaceutical CMO And CRO Market by Product
10.5.6.3 Rest of South and Central America Biopharmaceutical CMO And CRO Market
10.5.6.3.1 Rest of South and Central America Biopharmaceutical CMO And CRO Market by Source
10.5.6.3.2 Rest of South and Central America Biopharmaceutical CMO And CRO Market by Service Type
10.5.6.3.3 Rest of South and Central America Biopharmaceutical CMO And CRO Market by Product

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BIOPHARMACEUTICAL CMO AND CRO MARKET, KEY COMPANY PROFILES
12.1. AGC BIOLOGICS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TOYOBO CO., LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JRS PHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LONZA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PRA HEALTH SCIENCES, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PROBIOGEN AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. RENTSCHLER BIOPHARMA SE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SAMSUNG BIOLOGICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AGC Biologics
2. Boehringer Ingelheim International GmbH
3. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
4. TOYOBO CO., LTD
5. JRS PHARMA
6. Lonza
7. PRA Health Sciences, Inc.
8. ProBioGen AG
9. Rentschler Biopharma SE
10. Samsung BioLogics
TIPRE00007162
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.